Real world outcomes of sequencing bispecific antibodies (BsAb) in patients with relapsed / refractory follicular lymphoma (R/R FL): A multi-center cohort study from cubic consortium
Chijioke Nze(The University of Texas MD Anderson Cancer Center), Narendranath Epperla(University of Utah), Geoffrey Shouse(City Of Hope National Medical Center), Amrita Chauhan(Unknown), Yazeed Sawalha(Cleveland Clinic), Alex F. Herrera(City of Hope), Steven M. Bair(University of Colorado Cancer Center), Shakthi Bhaskar(Vanderbilt University Medical Center), Sairah Ahmed(The University of Texas MD Anderson Cancer Center), Allison M. Bock(Mayo Clinic), Yizhe Xu(Eurac Research), Amy Ayers(The University of Texas MD Anderson Cancer Center), Reid W. Merryman(Harvard University), Ajay Major(University of Colorado Cancer Center), Christopher R. Flowers(The University of Texas MD Anderson Cancer Center), Gilles Salles(Memorial Sloan Kettering Cancer Center), Jennifer L. Crombie(Dana-Farber Cancer Institute), Matthew A. Lunning(University of Nebraska Medical Center), Lorenzo Falchi(Memorial Sloan Kettering Cancer Center), Yuxin Zhao(Huntsman Cancer Institute), Swetha Kambhampati(City Of Hope National Medical Center), Andrew Jallouk(Vanderbilt University Medical Center), Omnia Farahat(The University of Texas MD Anderson Cancer Center), Christopher R. D’Angelo(Susan Thompson Buffett Foundation)
Cited by 0
Related Papers
The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee
|Blood|2022|1.5k
2016 US lymphoid malignancy statistics by World Health Organization subtypes
|CA A Cancer Journal for Clinicians|2016|1.1k
A catalog of genetic loci associated with kidney function from analyses of a million individuals
|Nature Genetics|2019|921
Standard-of-Care Axicabtagene Ciloleucel for Relapsed or Refractory Large B-Cell Lymphoma: Results From the US Lymphoma CAR T Consortium
|Journal of Clinical Oncology|2020|782
Rituximab in B-Cell Hematologic Malignancies: A Review of 20 Years of Clinical Experience
|Advances in Therapy|2017|603